Tag Archives: ipilimumab

November, 2018

July, 2018

November, 2017

July, 2017

January, 2016

October, 2015

  • 29 October

    FDA Expands Approval of BMS’ Yervoy in Melanoma

    PRINCETON, N.J., Oct 28, 2015 (BUSINESS WIRE) — Bristol-Myers Squibb Company BMY, +0.60% today announced that the U.S. Food and Drug Administration (FDA) has approved Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm …